HOLX

Hologic
D

HOLX

61.310
USD
-0.46
(-0.74%)
Market Open
Volume
29,835
EPS
4
Div Yield
-
P/E
19
Market Cap
13,757,327,112
Related Instruments
ABT
ABT
-1.300
(-0.98%)
131.320 USD
BDX
BDX
-2.790
(-1.22%)
226.280 USD
DGX
DGX
0.460
(0.27%)
169.560 USD
ISRG
ISRG
-5.50
(-1.11%)
489.98 USD
R
RGEN
-0.730
(-0.57%)
126.490 USD
SYK
SYK
-1.58
(-0.42%)
370.58 USD
T
TDOC
-0.19000
(-2.39%)
7.76000 USD
TMO
TMO
-12.82
(-2.58%)
484.20 USD
More
News

Title: Hologic

Sector: Healthcare
Industry: Medical Instruments & Supplies
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.